United States · Funded startup

Who invested in Black Diamond Therapeutics

2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$160Mraised across 2 rounds since 2019, from 2 sources

$85MSeries B$75MRound
Latest round
Round, $75MJun 2023
Biggest round
$85MSeries B · Jan 2019
Investors
8 (2 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20192020202120222023
$85MSeries B$75MRound
First round
Series B, $85M
Jan 2019
Biggest round
$85M
Series B · Jan 2019
Between rounds
4.4 years
from the last two

The rounds

  1. Jun 2023
  2. Jan 2019
    Series B$85M6 new

    Reported by PrnewswireSEC filing: $42M sold, first sale Dec 2018

Founders and team

From the SEC filings it signed: 4 on the team.

  • Brent M. Hatzis-SchochExecutive Officeri
  • Christopher M. RobertsExecutive Officeri
  • David M. EpsteinExecutive Officer, Directori
  • Thomas M. LeggettExecutive Officeri

On the board, as filediAlexander M. MaywegAli M. BehbahaniBradley M. BolzonGarry M. MenzelRajeev M. ShahSamarth M. Kulkarni

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

New Enterprise AssociatesVC firm2rounds, led 1
RA Capital ManagementPrivate equity2rounds, led 1
Perceptive AdvisorsAsset manager2rounds
Versant VenturesVC firm1round
Janus Henderson InvestorsPrivate equity1round
RA/ NexTech Investno record of our own yet1round
The Invus Groupno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Black Diamond Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Nextech InvestPrivate equityPer its own site
City Hill VenturesVC firm2020, per its site

Quick answers about Black Diamond Therapeutics

Who invested in Black Diamond Therapeutics?

Black Diamond Therapeutics's investors include New Enterprise Associates, RA Capital Management, Perceptive Advisors, Wellington Management and Versant Ventures, and 3 more on record.

How much has Black Diamond Therapeutics raised?

Black Diamond Therapeutics has raised $160M across 2 rounds since 2019.

When did Black Diamond Therapeutics last raise?

Black Diamond Therapeutics's most recent round was an Undisclosed round of $75M in Jun 2023.

What was Black Diamond Therapeutics's biggest round?

Black Diamond Therapeutics's largest round on record is $85M (Series B), in Jan 2019, led by New Enterprise Associates.

Who backed Black Diamond Therapeutics first?

Black Diamond Therapeutics's first round on record, in Jan 2019, was backed by New Enterprise Associates, RA Capital Management and Versant Ventures and 3 others.

What stage is Black Diamond Therapeutics at?

Black Diamond Therapeutics's latest named round is an Undisclosed round, in Jun 2023.

Where is Black Diamond Therapeutics based?

Black Diamond Therapeutics is based in the United States.

Who led Black Diamond Therapeutics's rounds?

New Enterprise Associates led the Series B in 2019.

Companies like Black Diamond Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.